BENZIMIDAZOLE COMPOUND
    1.
    发明申请
    BENZIMIDAZOLE COMPOUND 有权
    苯并咪唑化合物

    公开(公告)号:US20090203911A1

    公开(公告)日:2009-08-13

    申请号:US12189590

    申请日:2008-08-11

    IPC分类号: C07D405/14 C07D401/12

    摘要: A novel chemical compound useful as a therapeutic or prophylactic agent for acid-related diseases is provided, which has an excellent inhibitory effect against gastric acid secretion, an excellent effect of maintaining the inhibitory effect against gastric acid secretion, thereby maintaining intragastric pH high for a long time, and having more safety and appropriate physicochemical stability. Provided is a compound represented by where R1 and R3 may be the same or different and each represent a hydrogen atom or a C1-C6 alkyl group; R2 represents (5,5-dimethyl-1,3-dioxan-2-yl)methoxy group, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy group, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy group, or (2,2-dimethyl-1,3-dioxan-5-yl)methoxy group; R4, R5, R6 and R7 represent a hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 haloalkyl group, C1-C6 alkoxy group or C1-C6 haloalkoxy group; and W1 represents a single bond, methylene or ethylene group, a salt thereof or a solvate of these.

    摘要翻译: 提供了可用作酸性相关疾病的治疗或预防剂的新型化合物,其对胃酸分泌具有优异的抑制作用,保持对胃酸分泌的抑制作用的优异效果,从而保持胃内pH高 长时间,具有更多的安全性和适当的物理化学稳定性。 提供一种化合物,其中R 1和R 3可以相同或不同,各自表示氢原子或C 1 -C 6烷基; R2代表(5,5-二甲基-1,3-二恶烷-2-基)甲氧基,5,7-二氧杂螺[2.5]辛-6-基甲氧基,1,5,9-三氧杂螺[5.5]十一烷-3 - 甲氧基或(2,2-二甲基-1,3-二恶烷-5-基)甲氧基; R4,R5,R6和R7表示氢原子,卤素原子,C1-C6烷基,C1-C6卤代烷基,C1-C6烷氧基或C1-C6卤代烷氧基; W1表示单键,亚甲基或亚乙基,它们的盐或它们的溶剂合物。

    2-aminopyridine compounds and use thereof as drugs
    3.
    发明授权
    2-aminopyridine compounds and use thereof as drugs 失效
    2-氨基吡啶化合物及其作为药物的用途

    公开(公告)号:US06750232B2

    公开(公告)日:2004-06-15

    申请号:US10333689

    申请日:2003-01-23

    IPC分类号: C07D40102

    摘要: A class of substituted compounds is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by formula (II), wherein R1 is selected from hydrido, halo, alkoxy, aryl, alkylthio, alkylamino, aralkoxy, azido and alkenyloxy; wherein R2 is selected from hydrido, cyano, hydroxyalkyl, haloalkyl, aminoalkyl, alkylaminoalkyl, alkylcarbonyloxyalkyl, aminocarbonyl and alkylcarbonylaminoalkyl; and wherein R5 and R6 are one more radicals independently selected from halo, alkylsulfonyl, aminosulfonyl, alkoxy and alkylthio; provided one of R5 and R6 is substituted with alkysulfonyl, aminosulfonyl, or haloalkylsulfonyl; or a pharmaceutically-acceptable salt thereof.

    摘要翻译: 描述了一类取代的化合物用于治疗炎症和炎症相关疾病。 特别感兴趣的化合物由式(II)定义,其中R 1选自氢,卤素,烷氧基,芳基,烷硫基,烷基氨基,芳烷氧基,叠氮基和烯氧基; 氰基,羟基烷基,卤代烷基,氨基烷基,烷基氨基烷基,烷基羰氧基烷基,氨基羰基和烷基羰基氨基烷基;其中R 2选自氢,氰基, 并且其中R 5和R 6分别独立地选自卤素,烷基磺酰基,氨基磺酰基,烷氧基和烷硫基; 其中R 5和R 6之一被烷基磺酰基,氨基磺酰基或卤代烷基磺酰基取代; 或其药学上可接受的盐。